According to Zhitong Finance App, Lizhu Pharmaceutical (01513.HK) announced that on November 11, 2026, the company and Zhonghuiyuan entered into a share transfer agreement with Zhonghuiyuan. The company agreed to purchase about 0.13% of Zhonghuiyuan's shares in Xinbeiyuan Pharmaceutical (corresponding to the registered capital of Xinbeijiang Pharmaceutical of about RMB 303,600) in cash consideration. After the acquisition of Xinbeijiang Pharmaceutical Co., Ltd. is completed, the Company's direct interest in Xinbeijiang Pharmaceutical will increase from about 90.64% to about 90.77%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.